Taking DNA to market and regulatory default

Abstract

The public debate on recombinant DNA research has ended even though significant issues of public interest remain undecided or untouched. The reason for the termination of other than muted public discussion is not simply the removal of an initial fear of catastrophic biohazards. With the cessation of public debate over such hazards came also the dissolution of most public forums. The ends to which recombinant DNA research and development ought to be directed are not matters of public debate. With the transfer of basic research knowledge to the private sector, that sector's proprietary interests and ownership prerogatives effectively deny any continued public participation in charting the future of genesplicing technology and its application.